Document is current
Any future updates will be listed below
-
Authors
Chandrasekaran, Santosh
Wandelt, Sarah K.
Jangam, Aniket
Elias, Zeev
Ibroci, Erona https://orcid.org/0000-0002-7562-2985
Maffei, Christina
Rosenthal, Isabelle A.
Ramdeo, Richard
Kim, Joo-won
Xu, Junqian https://orcid.org/0000-0001-8438-2066
Glasser, Matthew F.
Neuwirth, Allison
Goldstein, Todd A.
Crone, Nathan E. https://orcid.org/0000-0001-7950-2617
Fifer, Matthew S. https://orcid.org/0000-0003-3425-7552
Tostaeva, Gelana https://orcid.org/0009-0005-8479-9351
Bickel, Stephan https://orcid.org/0000-0001-5265-2447
Griffin, Douglas
Funaro, Michael
Carras, Nicholas G.
Pruitt, Rachel
Ben-Shalom, Netanel
Stein, Adam B.
Mehta, Ashesh D.
Bouton, Chad E. https://orcid.org/0000-0002-6297-3890
-
Funding
Funding for this research was provided by:
in manuscript
New York State Department of Health (C37718GG)
- License Information
-
More Information
Article History
Received: 6 January 2026
Accepted: 2 June 2026
First Online: 16 July 2026
Ethics
Competing interests: C.E.B. has financial interests in Neuvotion, Inc., a medical device company developing neurotechnologies for restoring function after stroke or spinal cord injury, and Sanguistat, LLC, a company developing neurostimulation technologies to reduce blood loss; he also has multiple patents in the field of neuroprosthetics and related fields. The other authors declare no competing interests.
